Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Incyte

Combined immunotherapies – potential and pitfalls

Combined immunotherapies – potential and pitfalls The recent failed phase 3 trial of a combination of MSD’s monoclonal antibody Keytruda (pembrolizumab) and InCyte Corporation’s epacadostat in metastatic melanoma is a case in point he says.

CML-Life Patient Support Programme

Incyte listened to what we had to say, and developed something that we’ll actually use. ... CML-Life Patient Support Programme - by Incyte Biosciences with support from The EarthWorks (an Open Health Company).

Think Toddler Sized

by Incyte Biosciences with support from The EarthWorks (an Open Health Company). ... CML-Life Patient Support Programme - by Incyte Biosciences with support from The EarthWorks (an Open Health Company).

Small Talk Saves Lives

by Incyte Biosciences with support from The EarthWorks (an Open Health Company). ... CML-Life Patient Support Programme - by Incyte Biosciences with support from The EarthWorks (an Open Health Company).

Infantile Onset Pompe Disease Schools Pack

by Incyte Biosciences with support from The EarthWorks (an Open Health Company). ... CML-Life Patient Support Programme - by Incyte Biosciences with support from The EarthWorks (an Open Health Company).

[ Previous 5 results ] 2 3 4 5 6 7 8 9 10 11 [ Next 5 results ]

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

Report: Reinventing product and portfolio value for the biopharmaceutical industry
Gain practical advice on determining and communicating product and portfolio value, including why, in fast-paced and evolving markets, you need to consider the evidence requirements of a growing network of...
Neil Thompson
How AI is finally helping rare diseases gain more than just attention
By Neil Thompson...
Is communication failing us?
Compelling people to care in a world oversaturated with news and information...